Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma: An Assessment of Acute Toxicity and Long Term Neurocognitive, Neuroendocrine and Ototoxicity Outcomes

NCT01063114 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01063114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01063114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma: An Assessment of Acute Toxicity and Long Term Neurocognitive, Neuroendocrine and Ototoxicity Outcomes
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 8, 2010
Completion date
November 30, 2021
Enrollment
90 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, medulloblastoma, pineoblastoma